{"id":22425,"date":"2025-12-25T11:45:04","date_gmt":"2025-12-25T10:45:04","guid":{"rendered":"https:\/\/www.miph.gov.dz\/fr\/?page_id=22425"},"modified":"2026-07-07T11:16:31","modified_gmt":"2026-07-07T10:16:31","slug":"lignes-directrices","status":"publish","type":"page","link":"https:\/\/www.miph.gov.dz\/fr\/lignes-directrices\/","title":{"rendered":"Guides &#038; Lignes directrices &#8212; Guides &#038; Guidelines"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-25180 aligncenter\" src=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/07\/news-20.jpg\" alt=\"\" width=\"548\" height=\"309\" srcset=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/07\/news-20.jpg 1080w, https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/07\/news-20-300x169.jpg 300w, https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/07\/news-20-1024x576.jpg 1024w, https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/07\/news-20-768x432.jpg 768w\" sizes=\"auto, (max-width: 548px) 100vw, 548px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div style=\"width: 100%; max-width: none;\">\n<div class=\"accordion1\">\n<details>\n<summary>Lignes Directrices<\/summary>\n<div class=\"content\">\n<p><strong>05\/02\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/ligne-directrice-recours-et-plaintes-.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice relative aux plaintes et recours contre les d\u00e9cisions r\u00e9glementaires<\/strong><\/a><\/p>\n<p><strong>05\/02\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/FORMAT-ET-LE-CONTENU-DES-DEMANDES-DAUTORISATION-DIMPORTATION.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice sp\u00e9cifiant les conditions, le format et le contenu des demandes d\u2019autorisation d\u2019importation<\/strong><\/a><\/p>\n<p><strong>05\/02\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/NOMENCLATURE.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice relative <\/strong><strong>\u00e0 la mise \u00e0 jour de la nomenclature des produits pharmaceutiques et a sa publication<\/strong><\/a><\/p>\n<p><strong>05\/02\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/OBTENTION-DAGREMENT.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice relative \u00e0 l\u2019obtention de l\u2019agr\u00e9ment d\u2019un \u00e9tablissement pharmaceutique d\u2019importation, de distribution en gros et d\u2019exploitation<\/strong><\/a> <strong>(version 02)<\/strong><\/p>\n<p>05\/02\/2026<\/p>\n<p><strong><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/LD-reclamations.pdf\" target=\"_blank\" rel=\"noopener\">\u00a0Ligne directrice relative \u00e0 la gestion des r\u00e9clamations\u00a0<\/a><\/strong><strong>(Version N\u00b01)<\/strong><\/p>\n<p>04\/02\/2026<\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/finale-Ligne-Directrice-relative-a-lexportation-version-1.4-du-04.02.2026.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice Relative \u00e0 La D\u00e9livrance D\u2019autorisation D\u2019exportation Des Produits Pharmaceutiques et\/ou Des Dispositifs M\u00e9dicaux<\/strong><\/a><\/p>\n<p>04\/02\/2026<\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/LD-redaction-du-dossier-maitre-du-site-de-fabrication.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice Relative \u00e0 la r\u00e9daction du dossier ma\u00eetre du site (\u00e9tat des lieux des \u00e9tablissements pharmaceutiques de fabrication)\u00a0<\/strong><\/a><\/p>\n<p>04\/02\/2026<\/p>\n<p><strong><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/LD-depot-et-de-traitement-des-modifications-liees-aux-etablissements-pharmaceutiques-de-fabrication.pdf\" target=\"_blank\" rel=\"noopener\">Ligne directrice Relative aux modalit\u00e9s de d\u00e9p\u00f4t et de traitement des modifications li\u00e9es aux \u00e9tablissements pharmaceutiques de fabrication<\/a><\/strong><\/p>\n<p><strong>02\/02\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/LD-obtention-dagrement-de-fabrication.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice Relative \u00e0 l\u2019obtention d\u2019un agr\u00e9ment d\u2019un \u00e9tablissement pharmaceutique de fabrication<\/strong><\/a><strong> (Version N\u00b01)<\/strong><\/p>\n<p><strong>22\/01\/2026<\/strong><\/p>\n<p><strong><a href=\"https:\/\/miph.gov.dz\/wp-content\/uploads\/2026\/01\/LD-COMMUNICATION-DE-LINFORMATION-EN-INTERNE-ET-EN-EXTERNE-1.pdf\" target=\"_blank\" rel=\"noopener\">LIGNE DIRECTRICE POUR LA COMMUNICATION DE L\u2019INFORMATION EN INTERNE ET EN EXTERNE<\/a><\/strong><\/p>\n<p><strong>22\/01\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/01\/2026-01-21-1.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice pour l\u2019\u00e9laboration des textes l\u00e9gislatifs et r\u00e9glementaires<\/strong><\/a><\/p>\n<p><strong>11\/01\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/01\/LD-autorisation-dimportation.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice sp\u00e9cifiant les conditions, le format et le contenu des demandes d\u2019autorisation d\u2019importation<\/strong><\/a><\/p>\n<p><strong>08\/01\/2026<\/strong><\/p>\n<p><a href=\"https:\/\/miph.gov.dz\/wp-content\/uploads\/2026\/01\/ligne-directrice-agrement.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ligne directrice relative \u00e0 l\u2019obtention de l\u2019agr\u00e9ment d\u2019un \u00e9tablissement pharmaceutique d\u2019importation, de distribution en gros et d\u2019exploitation<\/strong><\/a><\/p>\n<p><strong>28\/12\/2025 \u00a0<\/strong><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/LIGNE-DIRECTRICE-POUR-LA-CONDUITE-DES-ETUDES-CLINIAQUES-EN-ALGERIE-V2-O.pdf\" target=\"_blank\" rel=\"noopener\">Ligne directrice relative \u00e0 la conduite des \u00e9tudes cliniques en Alg\u00e9rie<\/a>\u00a0<\/strong>(version 2)<\/li>\n<\/ul>\n<\/div>\n<\/details>\n<\/div>\n<div style=\"width: 100%; max-width: none;\">\n<div class=\"accordion1\">\n<details>\n<summary>Guides<\/summary>\n<div class=\"content\">\n<p><strong>01\/03\/2026\u00a0<\/strong><\/p>\n<h4><strong><a href=\"https:\/\/miph.gov.dz\/wp-content\/uploads\/2026\/03\/GUIDE-BPC-DZ-DRAFT.pdf\">Guide des bonnes pratiques cliniques applicable sur les \u00e9tudes cliniques en Alg\u00e9rie\u00a0<\/a><\/strong><\/h4>\n<p><strong>11\/02\/2026\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/02\/guide-des-bpd-et-bps.docx-V2.pdf\" target=\"_blank\" rel=\"noopener\">GUIDE DES BONNES PRATIQUES DE DISTRIBUTION ET DE STOCKAGE DES PRODUITS DE SANTE A USAGE HUMAIN<\/a>( version 2)<\/strong><\/p>\n<p><b>08\/04\/2026<\/b><\/p>\n<p style=\"text-align: justify;\"><b><a style=\"background-color: #ffffff; transition-property: all; text-align: left;\" href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2026\/04\/guide-importation-finale.pdf\" target=\"_blank\" rel=\"noopener\">Guide sur l\u2019application des dispositions d\u2019apposition du code-barres bidimensionnel(2D) Data Matrix Sur les produits pharmaceutiques import\u00e9s<\/a>\u00a0(Version 1.0)<\/b><\/p>\n<p><b>25\/12\/2025<\/b><\/p>\n<ul>\n<li style=\"text-align: justify;\"><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2025\/12\/guide-des-bpd-et-bps.pdf\" target=\"_blank\" rel=\"noopener\"><strong>GUIDE DES BONNES PRATIQUES DE DISTRIBUTION ET DE STOCKAGE DES PRODUITS DE SANTE A USAGE HUMAIN <\/strong><\/a><strong>( l\u2019ensemble des partie concern\u00e9es sont invit\u00e9es \u00e0 consulter ce guide et \u00e0 transmettre leurs observations et commentaires \u00e0 l\u2019adresse \u00e9lectronique suivante : regulation@miph.gov.dz)<\/strong><\/li>\n<\/ul>\n<p><strong>03\/06\/2022<\/strong><\/p>\n<p><a href=\"https:\/\/www.miph.gov.dz\/fr\/wp-content\/uploads\/2022\/09\/Guide-des-BPF2022.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Guide des bonnes pratiques de fabrication <\/strong><\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Lignes Directrices 05\/02\/2026 Ligne directrice relative aux plaintes et recours contre les d\u00e9cisions r\u00e9glementaires 05\/02\/2026 Ligne directrice sp\u00e9cifiant les conditions, le format et le contenu des demandes d\u2019autorisation d\u2019importation 05\/02\/2026 Ligne directrice relative \u00e0 la mise \u00e0 jour de la nomenclature des produits pharmaceutiques et a sa publication 05\/02\/2026 Ligne directrice relative \u00e0 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-22425","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/pages\/22425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/comments?post=22425"}],"version-history":[{"count":145,"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/pages\/22425\/revisions"}],"predecessor-version":[{"id":24258,"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/pages\/22425\/revisions\/24258"}],"wp:attachment":[{"href":"https:\/\/www.miph.gov.dz\/fr\/wp-json\/wp\/v2\/media?parent=22425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}